Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,346 Cr
up ₹233 Cr vs Sep 2025
- Stocks held
- 36
- down 1 vs Sep 2025
- Top 10 weight
- 58.5%
- of the portfolio in its ten largest
- Cash & debt
- 0.3%
- cash, money market and debt
- Moves this month
- 1 in · 2 out
- added to 10, trimmed 11
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In October 2025 it disclosed 36 stocks worth ₹8,346 Cr, up ₹233 Cr from Sep 2025. Its largest positions were Sun Pharmaceutical Industries Limited (12.7%), Divi's Laboratories Limited (8.1%), Lupin Limited (7.3%); the ten largest together made up 58.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 74.7% of its equity. Cash and debt stood at 0.3%. Compared with Sep 2025 the fund entered 1 new stock and exited 2.
Against 226 other Sectoral / Thematic funds
Concentration
80%
Top-10 weight is higher than 80% of peers
Breadth
31%
Holds more stocks than 31% of peers
Cash
4%
Holds more cash than 4% of peers
Holdings in October 2025
Download CSVEvery line the fund disclosed, with the change against Sep 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.67%
- Δ weight
- up 0.38 pts
- Value
- ₹1,058 Cr
- Δ value
- up ₹60.3 Cr
- Status
- Added
- Weight
- 8.07%
- Δ weight
- up 1.06 pts
- Value
- ₹674 Cr
- Δ value
- up ₹105 Cr
- Status
- Added
- Weight
- 7.26%
- Δ weight
- down 0.01 pts
- Value
- ₹606 Cr
- Δ value
- up ₹16.1 Cr
- Status
- Added
- Weight
- 6.29%
- Δ weight
- down 0.19 pts
- Value
- ₹525 Cr
- Δ value
- down ₹70 L
- Status
- Held
- Weight
- 5.97%
- Δ weight
- up 0.05 pts
- Value
- ₹498 Cr
- Δ value
- up ₹17.6 Cr
- Status
- Added
- Weight
- 5.62%
- Δ weight
- down 0.29 pts
- Value
- ₹469 Cr
- Δ value
- down ₹10.2 Cr
- Status
- Trimmed
- Weight
- 3.42%
- Δ weight
- down 0.14 pts
- Value
- ₹285 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 3.32%
- Δ weight
- down 0.07 pts
- Value
- ₹277 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 3.05%
- Δ weight
- down 0.19 pts
- Value
- ₹255 Cr
- Δ value
- down ₹8.3 Cr
- Status
- Trimmed
- Weight
- 2.87%
- Δ weight
- down 0.13 pts
- Value
- ₹239 Cr
- Δ value
- down ₹3.8 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- down 0.01 pts
- Value
- ₹237 Cr
- Δ value
- up ₹5.7 Cr
- Status
- Added
- Weight
- 2.81%
- Δ weight
- up 0.10 pts
- Value
- ₹235 Cr
- Δ value
- up ₹14.7 Cr
- Status
- Added
- Weight
- 2.59%
- Δ weight
- up 0.34 pts
- Value
- ₹216 Cr
- Δ value
- up ₹33.9 Cr
- Status
- Added
- Weight
- 2.39%
- Δ weight
- down 0.09 pts
- Value
- ₹199 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 2.32%
- Δ weight
- up 0.05 pts
- Value
- ₹194 Cr
- Δ value
- up ₹9.4 Cr
- Status
- Added
- Weight
- 2.29%
- Δ weight
- down 0.05 pts
- Value
- ₹191 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 2.16%
- Δ weight
- down 0.11 pts
- Value
- ₹181 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Weight
- 2.14%
- Δ weight
- down 0.03 pts
- Value
- ₹178 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 2.10%
- Δ weight
- up 0.12 pts
- Value
- ₹176 Cr
- Δ value
- up ₹14.7 Cr
- Status
- Added
- Weight
- 2.01%
- Δ weight
- down 0.09 pts
- Value
- ₹168 Cr
- Δ value
- down ₹2.7 Cr
- Status
- Trimmed
- Weight
- 1.99%
- Δ weight
- up 0.01 pts
- Value
- ₹166 Cr
- Δ value
- up ₹5.5 Cr
- Status
- Added
- Weight
- 1.95%
- Δ weight
- down 0.26 pts
- Value
- ₹162 Cr
- Δ value
- down ₹16.5 Cr
- Status
- Trimmed
- Weight
- 1.50%
- Δ weight
- up 0.15 pts
- Value
- ₹125 Cr
- Δ value
- up ₹15.4 Cr
- Status
- Added
- Weight
- 1.48%
- Δ weight
- up 0.05 pts
- Value
- ₹124 Cr
- Δ value
- up ₹7.6 Cr
- Status
- Added
- Weight
- 1.35%
- Δ weight
- up 0.03 pts
- Value
- ₹113 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 1.32%
- Δ weight
- down <0.01 pts
- Value
- ₹110 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 1.24%
- Δ weight
- down <0.01 pts
- Value
- ₹103 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 1.23%
- Δ weight
- up 1.23 pts
- Value
- ₹102 Cr
- Δ value
- up ₹102 Cr
- Status
- New
- Weight
- 1.00%
- Δ weight
- up 0.01 pts
- Value
- ₹83.2 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Weight
- 0.90%
- Δ weight
- down 0.09 pts
- Value
- ₹75.2 Cr
- Δ value
- down ₹5.4 Cr
- Status
- Trimmed
- Weight
- 0.84%
- Δ weight
- up 0.01 pts
- Value
- ₹69.8 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 0.74%
- Δ weight
- up <0.01 pts
- Value
- ₹62 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 0.72%
- Δ weight
- up 0.01 pts
- Value
- ₹59.8 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 0.61%
- Δ weight
- down 0.05 pts
- Value
- ₹51.2 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- up <0.01 pts
- Value
- ₹35.8 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.34%
- Δ weight
- down 0.19 pts
- Value
- ₹28 Cr
- Δ value
- down ₹14.7 Cr
- Status
- Trimmed
- Weight
- 0.19%
- Δ weight
- down 0.03 pts
- Value
- ₹16.1 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
What changed, Sep 2025 to Oct 2025
New New positions (1)
- Max Healthcare Institute Limited1.2% · ₹102 Cr
Exited Exited (2)
- Torrent Pharmaceuticals Limitedwas 1.3% · ₹109 Cr
- Zydus Lifesciences Limitedwas 0.2% · ₹19.1 Cr
Added Biggest additions
- Divi's Laboratories Limitedup ₹105 Cr (+1.06% pts)
- Sun Pharmaceutical Industries Limitedup ₹60.3 Cr (+0.38% pts)
- Thyrocare Technologies Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2025, the weight rose most in Healthcare Services (+1.2 pts), and fell most in Pharmaceuticals & Biotechnology (−1.1 pts).
- Healthcare Services20.1% → 21.3%+1.2 pts
- Pharmaceuticals & Biotechnology75.8% → 74.7%−1.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2022 | Oct 2024 | Apr 2025 | Jul 2025 | Sep 2025 | Oct 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 80.1% | 78.7% | 76.4% | 75.5% | 75.8% | 74.7% |
| Healthcare Services | 18.1% | 18.2% | 19.6% | 20.0% | 20.1% | 21.3% |
| Retailing | — | 2.5% | 3.6% | 3.9% | 3.4% | 3.3% |
| Pharmaceuticals | 1.4% | 0.7% | 0.5% | 0.7% | 0.7% | 0.6% |
Allocation in Oct 2025change vs Sep 2025
- Pharmaceuticals & Biotechnology (25)74.7%▼ 1.1 pts
- Healthcare Services (9)21.3%▲ 1.2 pts
- Retailing (1)3.3%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2025
0.3%
▼ 0.2 pts vs Sep 2025
- Cash alone
- 0.3%
- cash and net receivables
- A year earlier
- 4.4%
- Oct 2024 · now ▼ 4.1 pts
- Last 12 months
- 0.3% – 3.1%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.